All lectures are on Tuesdays from 12 to 1 p.m. in Comer Commons at Moores Cancer Center (directions and map). Lunch is available at 11:45 a.m. for those attending the lecture.
Principles of Cancer Drug Therapeutics Development
This is a required series of 12 weekly lectures delivered by CT2 and UC San Diego faculty members during fall quarter. They focus on the necessary sequential steps in drug development.
Topics in Cancer Drug Development
This is a series of 10 monthly lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.
2016-2017 Lecture Series
|1/10/17||Januario Castro, MD|
|RNA Splicing in Cancer|
|1/17/17||Ezra Cohen, MD|
|Immune Approaches in Head and Neck Cancer|
|1/24/17||Brett Monia||Ionis Pharmaceuticals||Antisense Strategies for Cancer Drug Development|
|2/7/17||Michael Rothenberg||Loxo Pharmaceuticals||Targeting Addicting Kinases in Cancer—a Drug Development Perspective|
|2/14/17||Hatim Hussain, MD|
|2/21/17||William Go, MD||Kite Pharmaceucticals||Anti-CD19 CAR T for B cell lymphoma|
|3/7/17||Michael Reich, PhD||Moores UCSD |
|Tools and Methods for Genomic Computation, Visualization, and Integration|
|3/14/17||Kathryn Gold, MD||Moores UCSD |
|Development of Ibrutinib for Solid Tumors|
|3/28/17||Adriana Comprelli||Bristol-Myers Squibb||TBD|
Schedules for previous years